Featured Research

from universities, journals, and other organizations

Risk of death is high in older adults with sleep apnea and daytime sleepiness, study finds

Date:
April 1, 2011
Source:
American Academy of Sleep Medicine
Summary:
A new study suggests that the risk of death is more than two times higher in older adults who have sleep apnea and report struggling with excessive daytime sleepiness.

A study in the April 1 issue of the journal Sleep suggests that the risk of death is more than two times higher in older adults who have sleep apnea and report struggling with excessive daytime sleepiness.

Results of adjusted proportional hazards modeling show that older adults with moderate to severe sleep apnea who reported struggling with excessive daytime sleepiness at baseline were more than twice as likely to die (hazard ratio = 2.28) as subjects who had neither problem. The risk of death was insignificant in older adults with only excessive daytime sleepiness (HR = 1.11) or sleep apnea (HR = 0.74). Participants had a mean age of 78 years at baseline, and about 55 percent (n = 160) died during an average follow-up period of 14 years.

"Excessive daytime sleepiness, when associated with sleep apnea, can significantly increase the risk of death in older adults," said principal investigator and lead author Dr. Nalaka S. Gooneratne, assistant professor of medicine in the University of Pennsylvania Health System in Philadelphia, Pa. "We did not find that being sleepy in and of itself was a risk. Instead, the risk of increased mortality only seemed to occur when sleep apnea was also present."

Gooneratne added that both daytime sleepiness and sleep apnea are common problems, with sleep apnea affecting up to 20 percent of older adults.

According to the American Academy of Sleep Medicine, the most common form of sleep apnea is obstructive sleep apnea, which occurs when soft tissue in the back of the throat collapses and blocks the upper airway during sleep. Older adults also are at risk for central sleep apnea, which involves a repetitive absence of breathing effort during sleep caused by a dysfunction in the central nervous system or the heart. Only four percent of participants had central sleep apnea, and there was no meaningful change in the results when they were excluded from the analysis.

The study involved 289 adults with neither dementia nor depression who were recruited from the community. Seventy-four percent were female. About half (n = 146) had significant levels of excessive daytime sleepiness at baseline, reporting that they felt sleepy or struggled to stay awake during the daytime at least three to four times a week. Sleep apnea was measured objectively by one night of polysomnography in a sleep lab. For analysis, participants were included in the sleep apnea group only if they had an apnea-hypopnea index of 20 or more breathing pauses per hour of sleep, which represents a moderate to severe level of sleep apnea.

Participants were recruited between 1993 and 1998. Survival status was determined by searching the social security death index, with follow-up ending Sept. 1, 2009.

According to the authors, the mechanism by which sleep apnea and excessive daytime sleepiness increase the risk of death is unclear. They suspect that inflammation may be involved, which could increase the risk of other medical problems such as hypertension. It also remains to be seen if treatment reduces the risk of death.

"Future research is needed to assess whether treating the sleep apnea can reduce mortality," said Gooneratne.

The treatment of choice for OSA is CPAP therapy, which provides a steady stream of air through a mask that is worn during sleep. This airflow keeps the airway open to prevent pauses in breathing and restore normal oxygen levels.

The study was supported by the National Institutes of Health through the National Institute on Aging and the National Center for Research Resources.

Help for people who have sleep apnea is available at more than 2,200 AASM-accredited sleep disorders centers across the U.S. An online directory of AASM-accredited sleep centers is available at www.sleepcenters.org.


Story Source:

The above story is based on materials provided by American Academy of Sleep Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Nalaka S. Gooneratne, Kathy C. Richards, Marshall Joffe, Regina W. Lam; Fran Pack, Bethany Staley, David F. Dinges, Allan I. Pack. Sleep Disordered Breathing with Excessive Daytime Sleepiness is a Risk Factor for Mortality in Older Adults. Sleep, 2011; 34 (4): 435-442 [link]

Cite This Page:

American Academy of Sleep Medicine. "Risk of death is high in older adults with sleep apnea and daytime sleepiness, study finds." ScienceDaily. ScienceDaily, 1 April 2011. <www.sciencedaily.com/releases/2011/04/110401085457.htm>.
American Academy of Sleep Medicine. (2011, April 1). Risk of death is high in older adults with sleep apnea and daytime sleepiness, study finds. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/04/110401085457.htm
American Academy of Sleep Medicine. "Risk of death is high in older adults with sleep apnea and daytime sleepiness, study finds." ScienceDaily. www.sciencedaily.com/releases/2011/04/110401085457.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins